PMV Pharmaceuticals Q2 EPS $(0.38) Down From $(0.29) YoY

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2022

1 minute read

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.38) per share. This is a 31.03 percent decrease over losses of $(0.29) per share from the same period last year.

EbixCash Travel Signs Sales Agreement With Malaysian And Saudi Arabian Travel Companies To Distribute EbixCash’s Via.Com Travel Products In These Countries

By Bill Haddad

Today, 10:23 PM

EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ:EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today

EBIX

M&A
News

Celanese Acquires POM Technology and Sales Agreements from Grupa Azoty

By Michael Horton

Today, 10:23 PM

Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced that it has acquired certain technology relating to the production of polyacetal (POM) products from Grupa Azoty S.A. of Tarnow, Poland, after its decision to discontinue its POM manufacturing.

Wall Street’s Most Accurate Analysts Say Hold These 3 Tech Stocks With Over 3% Dividend Yields

By Lisa Levin

Today, 10:23 PM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

FIS